Study identifier:SH-AHM-0013
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Comparison between candesartan cilexetil 16mg and lisinopril 20mg and their combination in patients with type II diabetes mellitus and microalbuminuria.- CALM Study.
diabetic retinopathy
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|